123 related articles for article (PubMed ID: 2873956)
21. Brain region differences and some characteristics of monoamine oxidase type A and B activities in the vervet monkey.
Murphy DL; Redmond DE; Garrick N; Baulu J
Neurochem Res; 1979 Feb; 4(1):53-62. PubMed ID: 109783
[TBL] [Abstract][Full Text] [Related]
22. Characterization of 1-Aminobenzotriazole and Ketoconazole as Novel Inhibitors of Monoamine Oxidase (MAO): An In Vitro Investigation.
Shaik AN; LeDuc BW; Khan AA
Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):827-834. PubMed ID: 28185143
[TBL] [Abstract][Full Text] [Related]
23. Effects of inhibitors on monoamine oxidase activity in mouse brain.
Hall TR; Figueroa HR; Yurgens PB
Pharmacol Res Commun; 1982 May; 14(5):443-53. PubMed ID: 6810387
[No Abstract] [Full Text] [Related]
24. Properties of monoamine oxidase in monkey heart.
Katayama M; Kobayashi S; Oguchi K; Yasuhara H
Jpn J Pharmacol; 1984 Aug; 35(4):425-31. PubMed ID: 6438377
[TBL] [Abstract][Full Text] [Related]
25. Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat.
Benedetti MS; Boucher T; Carlsson A; Fowler CJ
Biochem Pharmacol; 1983 Jan; 32(1):47-52. PubMed ID: 6830619
[TBL] [Abstract][Full Text] [Related]
26. Enzymic and molecular characteristics of a new form of monoamine oxidase, distinct from form-A and form-B.
Yoshino M; Obata T; Sho S; Kinemuchi H
Jpn J Pharmacol; 1984 Jun; 35(2):105-15. PubMed ID: 6748374
[TBL] [Abstract][Full Text] [Related]
27. Cloning of a novel monoamine oxidase cDNA from trout liver.
Chen K; Wu HF; Grimsby J; Shih JC
Mol Pharmacol; 1994 Dec; 46(6):1226-33. PubMed ID: 7808446
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effects of ethaverine, a homologue of papaverine, on monoamine oxidase activity in mouse brain.
Lee SS; Lee JJ; Cheong MJ; Kim YH; Kim Y; Yun YP; Lee CK; Lee MK
Biol Pharm Bull; 2001 Jul; 24(7):838-40. PubMed ID: 11456127
[TBL] [Abstract][Full Text] [Related]
29. Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity--an in vitro kinetic study.
Rao KS; Rao GV
Mol Cell Biochem; 1994 Aug; 137(1):57-60. PubMed ID: 7845378
[TBL] [Abstract][Full Text] [Related]
30. Multiple forms of monoamine oxidase in developing chick brain.
Suzuki O; Katsumata Y; Oya M; Asano M
Dev Neurosci; 1978; 1(3-4):172-6. PubMed ID: 756381
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of monoamine oxidase in zebrafish (Danio rerio).
Setini A; Pierucci F; Senatori O; Nicotra A
Comp Biochem Physiol B Biochem Mol Biol; 2005 Jan; 140(1):153-61. PubMed ID: 15621520
[TBL] [Abstract][Full Text] [Related]
32. 5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO).
Herraiz T; Brandt SD
Drug Test Anal; 2014; 6(7-8):607-13. PubMed ID: 24115740
[TBL] [Abstract][Full Text] [Related]
33. Organ distribution of aldehyde dehydrogenase activity in the rainbow trout (Salmo gairdneri Richardson).
Nilsson GE
Comp Biochem Physiol B; 1988; 90(1):109-11. PubMed ID: 3396318
[TBL] [Abstract][Full Text] [Related]
34. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
Obata T; Aomine M
Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123(1-6):13-26. PubMed ID: 22032088
[TBL] [Abstract][Full Text] [Related]
35. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
Lenzen S; Nahrstedt H; Panten U
Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
[TBL] [Abstract][Full Text] [Related]
36. In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks.
Wagmann L; Brandt SD; Kavanagh PV; Maurer HH; Meyer MR
Toxicol Lett; 2017 Apr; 272():84-93. PubMed ID: 28302559
[TBL] [Abstract][Full Text] [Related]
37. Rat and human cardiac monoamine oxidase: a comparison with other tissues.
Dial EJ; Clarke DE
Eur J Pharmacol; 1979 Oct; 58(3):313-9. PubMed ID: 510362
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
Malin DH; Moon WD; Goyarzu P; Barclay E; Magallanes N; Vela AJ; Negrete AP; Mathews H; Stephens B; Mills WR
Life Sci; 2013 Oct; 93(12-14):448-53. PubMed ID: 23988853
[TBL] [Abstract][Full Text] [Related]
39. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
40. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
Obata T; Aomine M
Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123():13-26. PubMed ID: 25022028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
